View in EDS

A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.

Saved in:
Bibliographic Details
Title: A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
Authors: Cescon DW; Princess Margaret Cancer Center, University Health Network and University of Toronto, Toronto, Ontario, Canada., Hilton J; Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada., Morales Murilo S; Lleida Biomedical Research Institute, Lleida, Spain., Layman RM; MD Anderson Cancer Center, Houston, Texas., Pluard T; Saint Luke's Cancer Institute, Kansas City, Missouri., Yeo B; Olivia Newton-John Cancer Research and Wellness Centre and Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia., Park IH; National Cancer Center, Goyang, Republic of South Korea.; Korea University Guro Hospital, Seoul, Republic of South Korea., Provencher L; CHU de Québec-Laval University, Québec City, Québec, Canada., Kim SB; Asan Medical Center, Seoul, Republic of South Korea., Im YH; Samsung Medical Center, Seoul, Republic of South Korea., Wyce A; GSK, Collegeville, Pennsylvania., Krishnatry AS; GSK, Collegeville, Pennsylvania., Hicks K; GSK, Collegeville, Pennsylvania., Zhang Q; GSK, Collegeville, Pennsylvania., Barbash O; GSK, Collegeville, Pennsylvania., Khaled A; GSK, Collegeville, Pennsylvania., Horner T; GSK, Collegeville, Pennsylvania., Dhar A; GSK, Collegeville, Pennsylvania., Oliveira M; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Sparano JA; Icahn School of Medicine, Tisch Cancer Institute, New York, New York (formerly Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York).
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 17; Vol. 30 (2), pp. 334-343.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37992310
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cescon+DW%22">Cescon DW</searchLink>; Princess Margaret Cancer Center, University Health Network and University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hilton+J%22">Hilton J</searchLink>; Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Morales+Murilo+S%22">Morales Murilo S</searchLink>; Lleida Biomedical Research Institute, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Layman+RM%22">Layman RM</searchLink>; MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Pluard+T%22">Pluard T</searchLink>; Saint Luke's Cancer Institute, Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Yeo+B%22">Yeo B</searchLink>; Olivia Newton-John Cancer Research and Wellness Centre and Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Park+IH%22">Park IH</searchLink>; National Cancer Center, Goyang, Republic of South Korea.; Korea University Guro Hospital, Seoul, Republic of South Korea.<br /><searchLink fieldCode="AU" term="%22Provencher+L%22">Provencher L</searchLink>; CHU de Québec-Laval University, Québec City, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Kim+SB%22">Kim SB</searchLink>; Asan Medical Center, Seoul, Republic of South Korea.<br /><searchLink fieldCode="AU" term="%22Im+YH%22">Im YH</searchLink>; Samsung Medical Center, Seoul, Republic of South Korea.<br /><searchLink fieldCode="AU" term="%22Wyce+A%22">Wyce A</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Krishnatry+AS%22">Krishnatry AS</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hicks+K%22">Hicks K</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Zhang+Q%22">Zhang Q</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Barbash+O%22">Barbash O</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Khaled+A%22">Khaled A</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Horner+T%22">Horner T</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Dhar+A%22">Dhar A</searchLink>; GSK, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Oliveira+M%22">Oliveira M</searchLink>; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sparano+JA%22">Sparano JA</searchLink>; Icahn School of Medicine, Tisch Cancer Institute, New York, New York (formerly Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2024 Jan 17; Vol. 30 (2), pp. 334-343.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37992310
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-23-0133
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 334
    Titles:
      – TitleFull: A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cescon DW
      – PersonEntity:
          Name:
            NameFull: Hilton J
      – PersonEntity:
          Name:
            NameFull: Morales Murilo S
      – PersonEntity:
          Name:
            NameFull: Layman RM
      – PersonEntity:
          Name:
            NameFull: Pluard T
      – PersonEntity:
          Name:
            NameFull: Yeo B
      – PersonEntity:
          Name:
            NameFull: Park IH
      – PersonEntity:
          Name:
            NameFull: Provencher L
      – PersonEntity:
          Name:
            NameFull: Kim SB
      – PersonEntity:
          Name:
            NameFull: Im YH
      – PersonEntity:
          Name:
            NameFull: Wyce A
      – PersonEntity:
          Name:
            NameFull: Krishnatry AS
      – PersonEntity:
          Name:
            NameFull: Hicks K
      – PersonEntity:
          Name:
            NameFull: Zhang Q
      – PersonEntity:
          Name:
            NameFull: Barbash O
      – PersonEntity:
          Name:
            NameFull: Khaled A
      – PersonEntity:
          Name:
            NameFull: Horner T
      – PersonEntity:
          Name:
            NameFull: Dhar A
      – PersonEntity:
          Name:
            NameFull: Oliveira M
      – PersonEntity:
          Name:
            NameFull: Sparano JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 01
              Text: 2024 Jan 17
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1